Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Genetic Variants Associated With Opioid Use Disorder

6 Feb 2023

Abstract excerpt

Genetics are presumed to contribute 30-40% to opioid use disorder (OUD), allowing for the possibility that genetic markers could be used to identify personal risk for developing OUD. We aimed to test the potential association among 180 candidate single nucleotide polymorphisms (SNPs), 120 of which were related to the dopamine reward pathway and 60 related to pharmacokinetics. Participants were randomly recruited...

Topics

Join the communities discussing this publication.

Pain Management and Opioid Use
Treatment of Major Depression

Source

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Identifiers

PMID: 36744646
DOI: 10.1002/cpt.2864

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 1 Sept 2026.

Community interpretation

Discuss the evidence

Ask a question, add context or challenge an interpretation. Community activity is separate from scientific evidence strength.

0

discussions

0

replies

Citations encouraged

Claims remain attributable.

No discussion yet

Be the first to add a careful, cited interpretation.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Genetic Variants Associated With Opioid Use DisorderPMID 36744646Read ↗

Genome-wide association analysis of opioid use disorder: A novel approach using clinical data.Semantic proximity Read ↗

Association of genetic variants in CYP3A5, DRD2 and NK1R with opioid overdose.Semantic proximity Read ↗

Genetic and Epigenetic Approaches to Opioid Use Disorder.Semantic proximity Read ↗

Identification of a sex-stratified genetic algorithm for opioid addiction risk.Semantic proximity Read ↗

Association of OPRM1 Functional Coding Variant With Opioid Use DisorderSemantic proximity Read ↗

Leveraging genome-wide data to investigate differences between opioid use vs. opioid dependence in 41,176 individuals from the Psychiatric Genomics Consortium.Semantic proximity Read ↗

Multi-variant Genetic Panel for Genetic Risk of Opioid Addiction.Semantic proximity Read ↗

Genome-wide association study in individuals of European and African ancestry and multi-trait analysis of opioid use disorder identifies 19 independent genome-wide significant risk loci.Semantic proximity Read ↗

Candidate Genes from an FDA-Approved Algorithm Fail to Predict Opioid Use Disorder Risk in Over 450,000 VeteransSemantic proximity Read ↗

A systematic review of GWAS identified SNPs associated with outcomes of medications for opioid use disorder.Semantic proximity Read ↗

Genome-wide analyses reveal novel opioid use disorder loci and genetic overlap with schizophrenia, bipolar disorder, and major depression.Semantic proximity Read ↗

The phenomics and genetics of addictive and affective comorbidity in opioid use disorderSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.